Simcere Pharmaceutical Group (NYSE:SCR)
CAPS Rating:
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
The World's Greatest Investing Community
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Why be bullish on a little known Chinese pharma company with an overheated Chinese market due for more correction? Because bottom line they are making drugs. Not just some designer drugs, they make generics(one slice of drug mkt), they have anti-cancer drugs(huge growth upside), they are buying or partnering with other companies who have products to distribute. They are positioning themselves for huge upside. Now for the bearish end, it just listed as an ADR in April 07, has been trending downward since, as of my choosing this they haven't announced 4Q 07 earnings yet. There seems to be a problem with newly listed Chinese ADRs at times, murky information, hopefully they will learn to put more news out there. So this could guide lower temporarily if earnings are missed (approx .12), If it beats then it is a great sign towards future growth and entrenchment into the Chinese pharma industry. Very thinly traded right now so any big stake is going to move it, as yet only 13% Institutional owners.